Proteomic analysis reveals differentially expressed proteins in the rat frontal cortex after methamphetamine treatment

Metabolic Brain Disease

Volumn 24, Issue 4, 2009, Pages 685-700

  Faure, J J ^a   Hattingh, S M ^a   Stein, D J ^b   Daniels, W M ^c  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Cytosolic proteins; Frontal cortex; Membrane proteins; Methamphetamine; Neuronal plasticity; Proteomics

Indexed keywords

APOMORPHINE; BETA SYNUCLEIN; CELL PROTEIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; CYTOSOLIC PROTEIN; GLUCOSE REGULATED PROTEIN 78; MEMBRANE PROTEIN; METHAMPHETAMINE; PSYCHOSTIMULANT AGENT; SYNAPSIN II; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; DRUG ABUSE; ENERGY METABOLISM; FRONTAL CORTEX; MALE; MASS SPECTROMETRY; NERVE CELL PLASTICITY; NONHUMAN; OXIDATION REDUCTION REACTION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEOMICS; RAT; SYNAPTIC TRANSMISSION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; AMPHETAMINE-RELATED DISORDERS; ANIMALS; BETA-SYNUCLEIN; BRAIN CHEMISTRY; CELL MEMBRANE; CYTOSOL; DISEASE MODELS, ANIMAL; DOPAMINE UPTAKE INHIBITORS; HEAT-SHOCK PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; METHAMPHETAMINE; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; PHOSPHOPYRUVATE HYDRATASE; PREFRONTAL CORTEX; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; SYNAPSINS; SYNAPTIC TRANSMISSION; UBIQUITIN THIOLESTERASE;

ANIMALIA; RATTUS;

EID: 74449084485     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11011-009-9167-0     Document Type: Article

References (68)

1. R Bryk P Griffin C Nathan 2000 Peroxynitrite reductase activity of bacterial peroxiredoxins Nature 407 211 215 10.1038/35025109 1:CAS:528:DC%2BD3cXmvVSmu74%3D 11001062
2. JL Cadet C Brannock 1998 Free radicals and the pathobiology of brain dopamine systems Neurochem Int 32 117 131 10.1016/S0197-0186(97)00031-4 1:CAS:528:DyaK1cXitVWjsLc%3D 9542724 (Pubitemid 28105298)
3. JL Cadet P Sheng S Ali R Rothman E Carlson C Epstein 1994 Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice J Neurochem 62 380 383 1:CAS:528:DyaK2cXmvFGhsw%3D%3D 7505315
4. BJ Carolan A Heguy BG Harvey PL Leopold B Ferris RG Crystal 2006 Up-regulation of expression of the ubiquitin carboxyl-terminal hydrolase L1 gene in human airway epithelium of cigarette smokers Cancer Res 66 10729 10740 10.1158/0008-5472.CAN-06-2224 1:CAS:528:DC%2BD2sXivVyqsLw%3D 17108109 (Pubitemid 44876968)
5. A Castegna M Aksenov M Aksenova V Thongboonkerd JB Klein WM Pierce R Booze WM Markesbery DA Butterfield 2002 Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1 Free Radic Biol Med 33 562 571 10.1016/S0891-5849(02)00914-0 1:CAS:528:DC%2BD38XlvVWmtLs%3D 12160938 (Pubitemid 34874977)
6. P Chan DA Monte JJ Luo LE DeLanney I Irwin JW Langston 1994 Rapid ATP loss caused by methamphetamine in the mouse striatum: relationship between energy impairment and dopaminergic neurotoxicity J Neurochem 62 2484 2487 1:CAS:528:DyaK2cXkt1Kktb0%3D 8189253
7. X Chen DR Tomchick E Kovrigin D Arac M Machius TC Sudhof J Rizo 2002 Three-dimensional structure of the complexin/SNARE complex Neuron 33 397 409 10.1016/S0896-6273(02)00583-4 1:CAS:528:DC%2BD38XjtlWntr4%3D 11832227 (Pubitemid 34158843)
8. Q Chen S Wang SN Thompson ED Hall RP Guttman 2006 Identification and characterization of PEPB as a calpain substrate J Neurochem 99 1133 1141 10.1111/j.1471-4159.2006.04160.x 1:CAS:528:DC%2BD28Xht1yks7vK 17018026 (Pubitemid 44655279)
9. LS Chin L Li A Ferreira KS Kosik P Greengard 1995 Impairment of axonal development and of synaptogenesis in hippocampal neurons of synapsin I-deficient mice Proc Natl Acad Sci USA 92 9230 9234 10.1073/pnas.92.20.9230 1:CAS:528:DyaK2MXosVWlt7g%3D 7568107
10. G Di Chara V Bassareo S Fenu MA De Luca L Spina C Cadoni C Acquas E Carboni V Valentina D Lecca 2004 Dopamine and drug addiction: the nucleus accumbens shell connection Neuropharmacology 47 227 241 10.1016/j.neuropharm. 2004.06.032 (Pubitemid 39298267)
11. JD Erickson LE Eiden BJ Hoffman 1992 Expression cloning of a reserpine-sensitive vesicular monoamine transporter Proc Natl Acad Sci USA 89 10993 10997 10.1073/pnas.89.22.10993 1:CAS:528:DyaK3sXkvV2ht7o%3D 1438304
12. BJ Everitt ME Wolf 2002 Psychomotor stimulant addiction: a neural systems perspective J Neurosci 22 3312 3320 1:CAS:528:DC%2BD38Xjs1ShurY%3D 11978805
13. E Fdez S Hilfiker 2006 Vesicle pools and synapsins: new insights into old enigmas Brain Cell Biol 35 107 115 10.1007/s11068-007-9013-4 17957477 (Pubitemid 47630632)
14. A Ferreira M Rapoport 2002 The synapsins: beyond the regulation of neurotransmitter release Cell Mol Life Sci 59 589 595 10.1007/s00018-002-8451-5 1:CAS:528:DC%2BD38XjtlWmtbw%3D 12022468 (Pubitemid 34457537)
15. A Ferreira HQ Han P Greengard KS Kosik 1995 Suppression of synapsin II inhibits the formation and maintenance of synapses in hippocampal culture Proc Natl Acad Sci USA 92 9225 9229 10.1073/pnas.92.20.9225 1:CAS:528: DyaK2MXosVWlt7s%3D 7568106
16. A Ferreira LS Chin L Li LM Lanier KS Kosik P Greengard 1998 Distinct roles of synapsin I and synapsin II during neuronal development Mol Med 4 22 28 1:CAS:528:DyaK1cXhslWjtLc%3D 9513186
17. F Fornai P Lenzi M Gesi M Ferrucci G Lazzeri L Capobianco A De Blasi G Battaglia F Nicoletti S Ruggieri A Paparelli 2004 Similarities between methamphetamine toxicity and proteasome inhibition Ann NY Acad Sci 1025 162 170 10.1196/annals.1316.021 1:CAS:528:DC%2BD2MXkvF2rsA%3D%3D 15542714 (Pubitemid 39643859)
18. F Fornai P Lenzi M Gesi P Soldani M Ferrucci G Lazzeri L Capobianco G Battaglia A De Blasi F Nicoletti A Paparelli 2004 Methamphetamine produces neuronal inclusions in the nigrostriatal system and in PC12 cells J Neurochem 88 114 123 1:CAS:528:DC%2BD2cXktVyquw%3D%3D 14675155
19. F Fornai G Lazzeri A Bandettini Di Poggio P Soldani A De Blasi F Nicoletti S Ruggieri A Paparelli 2006 Convergent roles of alpha-synuclein, DA metabolism, and the ubiquitin-proteosome system in nigrostriatal toxicity Ann NY Acad Sci 1074 84 89 10.1196/annals.1369.007 1:CAS:528:DC%2BD28XhtFGgs77F 17105905 (Pubitemid 44532812)
20. JW Gibb M Johnson GR Hanson 1990 Neurochemical basis of neurotoxicity Neurotoxicology 11 317 321 1:CAS:528:DyaK3cXmtVChurY%3D 1978271
21. N Hamajima K Matsuda S Sakata N Tamaki M Sasaki M Nonaka 1996 A novel gene family defined by human dihydropyrimidase and the three related proteins with differential tissue distribution Gene 180 157 163 10.1016/S0378-1119(96) 00445-3 1:CAS:528:DyaK28XntlOitLo%3D 8973361 (Pubitemid 26417923)
22. T Hamamura K Akiyama K Akimoto K Kashihara K Okumura H Ujike S Otsuki 1991 Co-administration of either a selective D1 or D2 dopamine antagonist withy methamphetamine prevents methamphetamine-induced behavioural sensitization and neurochemical change, studied by in vivo intracerebral dialysis Brain Res 546 40 46 10.1016/0006-8993(91)91156-U 1:CAS:528:DyaK3MXit1Whu7c%3D 1677305
23. RC Harris B Essen E Hultman 1976 Glycogen phosphorylase activity in biopsy samples and single muscle fibres of musculus quadriceps femoris of man at rest Scand J Clin Lab Invest 36 521 526 10.3109/00365517609054473 1:CAS:528:DyaE2sXhtFyiu7s%3D 1006142
24. T Hattori K Ohsawa Y Mizuno K Kato S Kohsaka 1994 Synthetic peptide corresponding to 30 aminoacids of the C terminal of neuron specific enolase promotes survival of neocortical neurons in culture Biochem Biophys Res Commun 202 25 30 10.1006/bbrc.1994.1888 1:CAS:528:DyaK2cXmt1Ohtbs%3D 8037719 (Pubitemid 24252560)
25. U Hengst H Albrecht D Hess D Monard 2001 The phosphatidylethanolamine- binding protein is the prototype of a novel family of serine protease inhibitors J Biol Chem 276 535 540 10.1074/jbc.M002524200 1:CAS:528:DC%2BD3MXmtFSqtw%3D%3D 11034991 (Pubitemid 32050348)
26. B Hofmann HJ Hecht L Flohe 2002 Peroxiredoxins Biol Chem 383 347 364 10.1515/BC.2002.040 1:CAS:528:DC%2BD38XksVajtro%3D 12033427 (Pubitemid 34506276)
27. S Huntwork JT Littleton 2007 A complexin fusion clamp regulates spontaneous neurotransmitter release and synaptic growth Nat Neurosci 10 1235 1237 10.1038/nn1980 1:CAS:528:DC%2BD2sXhtVOrsLrM 17873870 (Pubitemid 47480302)
28. T Iwazaki IS McGregor I Matsumoto 2006 Protein expression profile in the striatum of acute methamphetamine-treated rats Brain Res 1097 19 25 10.1016/j.brainres.2006.04.052 1:CAS:528:DC%2BD28XmslGht7k%3D 16729985 (Pubitemid 44041284)
29. T Iwazaki IS McGregor I Matsumoto 2007 Protein expression profile in the striatum of rats with methamphetamine-induced behavioural sensitization Proteomics 7 1131 1139 10.1002/pmic.200600595 1:CAS:528:DC%2BD2sXksFSlurY%3D 17351886 (Pubitemid 46649162)
30. T Iwazaki IS McGregor I Matsumoto 2008 Protein expression profile in the amygdala of rats with methamphetamine-induced behavioural sensitization Neurosci Lett 435 113 119 10.1016/j.neulet.2008.02.025 1:CAS:528:DC%2BD1cXktVClurs%3D 18346852
31. S Jayanthi B Ladenheim JL Cadet 1998 Methamphetamine-induced changes in antioxidant enzymes and lipid peroxidation in copper/zinc-superoxide dismutase transgenic mice Ann NY Acad Sci 844 92 102 10.1111/j.1749-6632.1998.tb08224.x 1:CAS:528:DyaK1cXks12lsrs%3D 9668667 (Pubitemid 28367798)
32. PW Kalivas J Stewart 1991 Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity Brain Res Brain Res Rev 16 223 244 10.1016/0165-0173(91)90007-U 1:CAS:528: DyaK38XhsVeqsLk%3D 1665095
33. PW Kalivas N Volkow J Seamans 2005 Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission Neuron 45 647 650 10.1016/j.neuron.2005.02.005 1:CAS:528:DC%2BD2MXis1yrs78%3D 15748840 (Pubitemid 40320699)
34. MW Kilimann G Isenberg 1982 Actin filament capping protein from bovine brain EMBO J 1 889 894 1:CAS:528:DyaL38XlsVSmt7o%3D 7188363
35. SJ Kim IK Lyoo J Hwang YH Sung HY Lee DS Lee DU Jeong PF Renshaw 2005 Frontal glucose hypometabolism in abstinent methamphetamine users Neuropsychopharmacology 30 1383 1391 1:CAS:528:DC%2BD2MXlt1KmsL4%3D 15726115 (Pubitemid 40848092)
36. FH Kobeissy MW Warren AK Ottens S Sadasivan Z Zhang MS Gold KKW Wang 2008 Psychoproteomic analysis of rat cortex following acute methamphetamine exposure J Proteome Res 7 1971 1983 10.1021/pr800029h 1:CAS:528:DC%2BD1cXlt1yjurw%3D 18452277
37. KH Lee 2001 Proteomics: a technology-driven and technology-limited discovery science Trends Biotechnol 9 217 222 10.1016/S0167-7799(01)01639-0 (Pubitemid 32441723)
38. TS Lewis JB Hunt LD Aveline KR Jonscher DF Louie JM Yeh TS Nahreini KA Resing NG Ahn 2000 Identification of novel MAP kinase pathway signalling targets by functional proteomics and mass spectrometry Mol Cell 6 1343 1354 10.1016/S1097-2765(00)00132-5 1:CAS:528:DC%2BD3MXlvFahtA%3D%3D 11163208 (Pubitemid 32045927)
39. L Li LS Chin O Shupliakov L Brodin TS Sihra O Hvalby V Jensen D Zheng JO McNamara P Greengard P Anderson 1995 Impairment of synaptic vesicle clustering and of synaptic transmission, and increased seizure propensity, in synapsin I-deficient mice Proc Natl Acad Sci USA 92 9235 9239 10.1073/pnas.92.20.9235 1:CAS:528:DyaK2MXosVWlt7k%3D 7568108
40. Li W, Wang H, Qiu P, Luo H (2008). Proteomics profiling of proteins asociated methamphetamine-induced neurotoxicity in different regions of rat brain. Neurochem Int 52:256-264.
41. P-C Liao Y-M Kuo H-C Hsu CG Cherng Y Lung 2005 Local proteins associated with methamphetamine-induced nigrostriatal dopaminergic neurotoxicity J Neurochem 95 160 168 10.1111/j.1471-4159.2005.03346.x 1:CAS:528: DC%2BD2MXhtVygs7fK 16181420 (Pubitemid 41384434)
42. J Lowe H McDermott M Landon RJ Mayer KD Wilkinson 1990 Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases J Pathol 161 153 160 10.1002/path.1711610210 1:CAS:528:DyaK3MXktVKgsLg%3D 2166150 (Pubitemid 20195792)
43. KE Marz PI Hanson 2002 Sealed with a twist: complexin and the synaptic SNARE complex Trends Neurosci 25 381 383 10.1016/S0166-2236(02)02207-5 1:CAS:528:DC%2BD38XlsVOlsLs%3D 12127744 (Pubitemid 34804452)
44. UD McCann GA Ricaurte 2004 Amphetamine neurotoxicity: accomplishments and remaining challenges Neurosci Biobehav Rev 27 821 826 10.1016/j.neubiorev.2003. 11.003 1:CAS:528:DC%2BD2cXhtV2iu7o%3D 15019431 (Pubitemid 38199612)
45. JA Morris AJ Dorner CA Edwards LM Hendershot RJ Kaufman 1997 Immunoglobulin binding protein (BiP) function is required to protect cells from endoplasmic reticulum stress but is not required for the secretion of selective proteins J Biol Chem 272 4327 4334 10.1074/jbc.272.7.4327 1:CAS:528: DyaK2sXht1yhsrw%3D 9020152 (Pubitemid 27078506)
46. EJ Nestler 2001 Molecular basis of long-term plasticity underlying addiction Nat Rev Neurosci 2 119 128 10.1038/35053570 1:CAS:528: DC%2BD3MXisl2qu78%3D 11252991 (Pubitemid 33673366)
47. IV Peshenko H Shichi 2001 Oxidation of active center cysteine of bovine 1-Cys peroxiredoxin sulfenic acid form by peroxide and peroxynitrite Free Radic Biol Med 31 292 303 10.1016/S0891-5849(01)00579-2 1:CAS:528:DC%2BD3MXlt1Smsbs%3D 11461766 (Pubitemid 32675334)
48. RC Pierce V Kumaresan 2006 The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse? Neurosci Biobehav Rev 30 215 238 10.1016/j.neubiorev.2005.04.016 1:CAS:528:DC%2BD2MXhtlCrsL3O 16099045 (Pubitemid 41821810)
49. VA Pieribone O Shupliakov L Brodin S Hilfiker-Rothenfluh AJ Czernik P Greengard 1995 Distinct pools of synaptic vesicles in neurotransmitter release Nature 375 493 497 10.1038/375493a0 1:CAS:528:DyaK2MXmtFCgsLc%3D 7777058
50. LB Poole HR Ellis 1996 Flavin-dependent alkyl hydroperoxide reductase from Salmonella typhimurium. 1. Purification and enzymatic activities of overexpressed AhpF and AhpC proteins Biochemistry 35 56 64 10.1021/bi951887s 1:CAS:528:DyaK2MXpvFWhsb8%3D 8555198 (Pubitemid 26036406)
51. K Reim M Mansour F Varoqueaux HT McMahon TC Sudhof N Brose C Rosenmund 2001 Complexins regulate a late step in Ca2+-dependent neurotransmitter release Cell 104 71 81 10.1016/S0092-8674(01)00192-1 1:CAS:528:DC%2BD3MXis1Oqsrc%3D 11163241 (Pubitemid 32144973)
52. GA Ricaurte RW Guillery LS Seiden CR Schuster RY Moore 1982 Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain Brain Res 235 93 103 10.1016/0006-8993(82)90198-6 1:CAS:528: DyaL38XhtlGrsbw%3D 6145488 (Pubitemid 12188130)
53. TW Rosahl D Spillane M Missler J Herz DK Selig JR Wolff RE Hammer RC Malenka TC Sudhof 1995 Essential functions of synapsin I and II in synaptic vesicle regulation Nature 375 488 493 10.1038/375488a0 1:CAS:528: DyaK2MXmtFCgsLY%3D 7777057
54. DR Royall 2002 Executive control function: a review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association J Neuropsychiatry Clin Neurosci 14 377 405 12426407
55. A Slivka C Cohen 1985 Hydroxyl radical attack on dopamine J Biol Chem 260 15466 15472 1:CAS:528:DyaL2MXlvFSns7Y%3D 2999117
56. TC Sudhof 2004 The synaptic vesicle cycle Annu Rev Neurosci 27 509 547 10.1146/annurev.neuro.26.041002.131412 15217342 (Pubitemid 39050412)
57. Vale RD, Banker G, Hall ZW (1992) The neuronal cytoskeleton. In: Hall ZW (ed) An introduction to molecular neurobiology. Sinuaer, Sunderland, pp 247-280
58. MP Vawter L Thatcher N Usen TM Hyde JE Kleinman WJ Freed 2002 Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia Mol Psychiatry 7 571 578 10.1038/sj.mp.4001158 1:CAS:528:DC%2BD38XlsFWrtL8%3D 12140780 (Pubitemid 34888420)
59. M Villanueva K Thornley GJ Augustine RM Wightman 2006 Synapsin II negatively regulates catecholamine release Brain Cell Biol 35 125 136 10.1007/s11068-007-9015-2 1:CAS:528:DC%2BD2sXht1anu7rM 17957479 (Pubitemid 47630634)
60. ND Volkow JS Fowler G-J Wang 2003 The addicted human brain: insights from imaging studies J Clin Invest 111 1444 1451 1:CAS:528:DC%2BD3sXktVGis7s%3D 12750391
61. MW Warren FH Kobeissy MC Liu RL Hayes MS Gold KK Wang 2005 Concurrent calpain and caspase-3 mediated proteolysis of alpha II-spectrin and tau in rat brain after methamphetamine exposure: a similar profile to traumatic brain injury Life Sci 78 301 309 10.1016/j.lfs.2005.04.058 1:CAS:528: DC%2BD2MXhtFOgtr%2FK 16125733 (Pubitemid 41570201)
62. MW Warren W Zheng FH Kobeissy M Cheng Liu RL Hayes MS Gold SF Larner KK Wang 2007 Calpain- and caspase-mediated alphaII-spectrin and tau proteolysis in rat cerebrocortical neuronal cultures after ecstasy or methamphetamine exposure Int J Neuropsychopharmacol 10 479 489 10.1017/S1461145706007061 1:CAS:528:DC%2BD2sXnt1KgtrY%3D 16882358 (Pubitemid 46985254)
63. E Weihe LE Eiden 2000 Chemical neuroanatomy of the vesicular amine transporters FASEB J 14 2435 2449 10.1096/fj.00-0202rev 1:CAS:528: DC%2BD3MXht1Snt7o%3D 11099461
64. CJ Wilhelm RA Johnson AJ Eshleman A Janowsky 2006 Hydrogen ion concentration differentiates effects of methamphetamine and dopamine on transporter-mediated efflux J Neurochem 96 1149 1159 10.1111/j.1471-4159.2005. 03611.x 1:CAS:528:DC%2BD28XivFWjs7s%3D 16417578
65. M Xue K Reim X Chen HT Chao H Deng J Rizo N Brose C Rosenmund 2007 Distinct domains of complexin I differentially regulate neurotransmitter release Nat Struct Mol Biol 14 949 958 10.1038/nsmb1292 1:CAS:528:DC%2BD2sXhtFWhs77E 17828276 (Pubitemid 47525173)
66. K Yamada T Nagai T Nabeshima 2005 Drug dependence, synaptic plasticity, and tissue plasminogen activator J Pharmacol Sci 97 157 161 10.1254/jphs. CP0040014 1:CAS:528:DC%2BD2MXhvFKlsLc%3D 15684570 (Pubitemid 40410252)
67. Yang MH, Kim S, Jung MS, Shim JH, Ryu NK, Yook YJ, Jang CG, Bahk YY, Kim KW, Park JH (2008). Proteomic analysis of methamphetamine-induced reinforcement processes within the mesolimbic dopamine system. Addict Biol 13:287-294
68. NR Zahniser A Sorkin 2004 Rapid regulation of the dopamine transporter: role in stimulant addiction? Neuropharmacology 47 80 91 10.1016/j.neuropharm. 2004.07.010 1:CAS:528:DC%2BD2cXotF2htr4%3D 15464127 (Pubitemid 39298254)